SOUTH JORDAN — Medical-devices manufacturer Merit Medical Systems Inc. has completed a three-way deal with Vysera Biomedical Ltd., based in Galway, Ireland, that is designed to provide Merit access to certain intellectual property and information about valve technology, opportunities to commercialize certain biomaterial technology and equity ownership in Vysera.
Among the provisions are Merit being provided with an equity investment of approximately $2.4 million, which will give Merit an approximate 14.45 percent fully diluted participating equity interest in Vysera. Fred P. Lampropoulos, Merit's chairman and chief executive officer, has been elected as a director of Vysera.
The total amount paid by Merit to Vysera in license fees and equity purchase payments is approximately $3.9 million.